<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Clearmind Medicine Inc (CMND)</title>
    <description>Latest news, press releases, and SEC filings for Clearmind Medicine Inc (CMND)</description>
    <link>https://caymanjournal.com/stock/CMND</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Tue, 28 Apr 2026 04:53:37 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/CMND/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>6-K — Clearmind Medicine Inc.</title>
      <description># 📰 What This Document Is
This filing is an SEC Form 6-K, which is a type of filing used by foreign private issuers (like Clearmind Medicine) to announce material information to U.S. investors. Essentially, this document is a press release designed to inform the public and potential investors about</description>
      <link>https://caymanjournal.com/stock/CMND/sec-filing/0001213900-26-045585</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/CMND/sec-filing/0001213900-26-045585</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>6-K — Clearmind Medicine Inc.</title>
      <description># 🧾 What This Document Is
This is a **6-K filing**, which is a report public foreign companies (like this Canadian one) file with the SEC to share important news. Think of it as a formal press release channel. This specific one announces a positive update from their ongoing clinical trial.

👉 **Th</description>
      <link>https://caymanjournal.com/stock/CMND/sec-filing/0001213900-26-036044</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/CMND/sec-filing/0001213900-26-036044</guid>
      <pubDate>Mon, 30 Mar 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>